Browsing by Author "Eglite, Jeļena"

Now showing 1 - 5 of 5
  • No Thumbnail Available
    Item
    Association of non-invasive markers of liver fibrosis with HCV coinfection and antiretroviral therapy in patients with HIV
    (2019-08-01) Koļesova, Oksana; Eglite, Jeļena; Koļesovs, Aleksandrs; Krumiņa, Angelika; Ekšteina, Ilze; Madelane, Monta; Viksna, Ludmila; Klīniskās imunoloģijas un imunoģenētikas starpkatedru laboratorija; Department of Infectology
    The aim of this study was to assess the main effects and interaction between viral hepatitis C (HCV) coinfection and antiretroviral therapy (ART) by using a nonparametric ANOVA on direct and indirect markers of liver fibrosis in HIV-infected patients. The sample included 178 HIV patients aged from 23 to 65 (36% females). The following parameters were determined in blood of patients: hyaluronic acid, pro-matrix metalloproteinase-1, alanine aminotransferase, aspartate aminotransferase, and platelet count. The FIB-4 index was also calculated. The nonparametric ANOVA revealed no significant interaction between HCV coinfection and ART. This provides evidence for an independent contribution of each factor on promotion of the pathology. The results also demonstrated that the direct and indirect indicators of liver fibrosis are associated differently with the studied factors. Therefore, a combination of markers should be used for monitoring of liver fibrosis in HIV-infected patients.
  • No Thumbnail Available
    Item
    Distribution of HLA allele frequencies in patients with cystic and alveolar echinococcosis in Latvia
    (2019-08-01) Laivacuma, Sniedze; Eglite, Jeļena; Derovs, Aleksejs; Viksna, Ludmila; Department of Infectology; Klīniskās imunoloģijas un imunoģenētikas starpkatedru laboratorija; Department of Internal Diseases
    The aim of this study was to assess the relationship between HLA Class II alleles in two groups of patients in Latvia: patients with cystic and alveolar echinococcosis. The study included 37 patients from the Rīga East Clinical University Hospital with echinococcosis (29 patients with cystic echinococcosis and eight patients with alveolar echinococcosis) and 100 healthy control persons without echinococcosis. HLA Class II allele genotyping was performed using Real-time polymerase chain reaction-sequence specific primer (RT-PCR-SSP). The odds ratios (OR), with 95% confidence intervals (95% CI), were calculated using statistical analysis performed with IBM SPSS Statistics for Windows, Version 22.0, to evaluate the risk of developing the disease in an individual having a particular HLA genotype. In the case of cystic echinococcosis a more severe course of a disease can be anticipated in the presence of HLA-DRB1 alleles ∗17:01 and ∗07:01, -DQB1 ∗03:02, and ∗03:01, -DQA1∗04:01 and haplotypes HLA-DRB1∗04:01/-DQB1∗03:01/ -DQA1∗03:01, HLADRB1∗11:01/ -DQB1∗03:01 /-DQA1∗05:01. However, in the group with alveolar echinococcosis it was associated with the HLA-DRB1 alleles ∗17:01 and ∗07:01, -DQB1 ∗05:01 and haplotypes HLA- DRB1∗17:01/-DQB1∗02:01-2/-DQA1∗01:01, HLA-DRB1∗11:01/ -DQB1∗03:01/-DQA1∗01:03 and HLA-DRB1∗11:01/-DQB1∗03:01/-DQA1∗03:01. HLADRB1∗15:01/-DQÂ1∗06:02-8/-DQA1∗05:01 and HLA-DRB1∗13:01/-DQB1∗02:01-2/-DQA1∗05:01 haplotypes were protective in all patient groups. The limitations of this exploratory study indicate that a broader study needs to be conducted for revealing specific risk and protective HLA Class II haplotypes for patients with cystic and alveolar echinococcosis in Latvia.
  • No Thumbnail Available
    Item
    HLA II class alleles in juvenile idiopathic arthritis patients with and without temporomandibular joint arthritis
    (2016-04-19) Davidsone, Zane; Eglite, Jeļena; Lazareva, Arina; Dzelzite, Sarmite; Šantere, Ruta; Berziņa, Dace; Staņeviča, Valda; Department of Paediatrics; Klīniskās imunoloģijas un imunoģenētikas starpkatedru laboratorija
    Background: Temporomandibular joint (TMJ) arthritis is seen very often (38-87 %) in children with juvenile idiopathic arthritis (JIA). With contrast enhanced magnetic resonance imaging (MRI) we can detect more cases of TMJ arthritis than ever before. Previous studies show that HLA II class alleles may have protective or risk importance in JIA subtypes. Our objective is to identify HLA II class alleles of risk and protection in JIA patients with TMJ arthritis. Methods: During the period from 2010 to 2015 MRI for TMJ was performed in 85 JIA patients who were genotyped for HLA- DRB1; DQB1 and DQA1 using RT-PCR with sequence-specific primers. As a control group, data of 100 individuals were taken from the genetic bank of RSU Joint Laboratory of Clinical Immunology and Immunogenetics. Associations of DRB1; DQB1; DQA1 alleles in patients were examined individually using the χ 2 test. P-value (<0.05) and odds ratio were calculated using EPI INFO 6.0 software. Results: Out of 85 JIA patients with mean age of 13.7 ± 3.0 years (range 6.9-17.9 years), 59 (69 %) were girls and 26 (31 %) were boys. The mean duration of the disease was 3.07 ± 2.35 years (range 0.2-11.0 year). JIA subtypes were as follows: seronegative polyarthritis 51 (60 %), seropositive polyarthritis 6(7 %), oligoarthritis extended 7(8 %), oligoarthritis persistent 2 (2 %) arthritis with enthesitis 14 (17 %), undifferentiated 3 (4 %) and 2 (2 %) systemic arthritis. Two groups where separated after TMJ MRI exam: first with at least two signs of active inflammation and/or any structural damage (n = 62); second with no pathologic signs or with slight contrast enhancement (n = 23). We discovered that there are risk alleles that are found in all JIA patient's groups (MRI positive and negative groups) versus controls such as DRB1*07:01, DQB1*03:03; DQB1*05:01. Also some protective alleles as DRB1*18:01, DQB1*06:02-8 were found in overall JIA group. Alleles DRB1*12:01, DQB1*03:01; DQA1*05:01 were found to be protective for TMJ arthrits. Conclusion: In our study there were no convincing risk alleles, but there are alleles that probably are protective for TMJ arthritis like DRB1*12:01, DQB1*03:01; DQA1*05:01.
  • No Thumbnail Available
    Item
    Human leukocyte antigens class II alleles affecting the response to 5-7 year antiretroviral therapy in A Latvian cohort
    (2019-05-01) Jasinskis, Vladislavs; Koļesova, Oksana; Koļesovs, Aleksandrs; Rozentale, Baiba; Ažiņa, Inga; Kramiča, Ksenija; Viksna, Ludmila; Eglite, Jeļena; Klīniskās imunoloģijas un imunoģenētikas starpkatedru laboratorija; Department of Infectology
    Antiretroviral therapy (ART) aims at suppressing viral replication and strengthening immune system in patients with HIV-1. Human Leukocyte Antigens (HLA) are among factors responsible for effectiveness of ART. The aim of this study was to determine the effect of HLA Class II alleles on the response to long-time ART, assessed by a change in CD4 + T-cell count in relation to viral load. The sample included 69 patients (17 females and 52 males) aged 20 to 50 with HIV-1 infection, who were undergoing ART in the Latvian Centre of Infectious Diseases. The median period of observation was 5.7 years. CD4 + T-cell count and viral load were analysed at the baseline and end of the period of observation. HLA typing was performed by polymerase chain reaction with low resolution sequence specific primers. Multiple hierarchical linear regression analysis confirmed that an increase in HIV-1 viral load was associated with a decrease in the level of CD4 + T-cell count. In addition, HLA-DRB1∗04 and HLA-DQB1∗06:01 alleles contributed negatively to the level of CD4 + T-cell count.
  • No Thumbnail Available
    Item
    A pilot study on markers of genetic predisposition in tuberculous pneumonia patients in Latgale
    (2019-05-01) Kramiča, Ksenija; Eglite, Jeļena; Koļesovs, Aleksandrs; Kramiča, Tatjana; Titoviča, Gaļina; Džeriņa, Diana; Nikolajeva, Glafira; Viksna, Ludmila; Koļesova, Oksana; Klīniskās imunoloģijas un imunoģenētikas starpkatedru laboratorija; Department of Infectology
    Tuberculosis (TB) is still one of the top ten leading causes of death in the world. Compared to other Baltic and Eastern European countries, TB incidence (24.8 new cases per 100 000 people in 2017) in Latvia is relatively high. One of the regions with the highest TB incidence is Latgale (31.1 cases per 100 000 people). The aim of this pilot study was to identify markers of genetic predisposition to TB in Latgale. The study included 26 patients (16 males and 10 females) aged between 18 and 85 with bilateral TB pneumonia and without HIV infection. HLA typing was performed in HLA-DRB1, -DQA1, and -DQB1 loci by a polymerase chain reaction with low resolution sequence-specific primers. HLA-DRB1∗07 and HLA-DRB1∗11 alleles were identified as risk alleles for TB. HLA-DRB1∗15 allele was a protective allele. Due to the limitations of this exploratory study, a broader study needs to be conducted to revealing specific risk and protective HLA Class II alleles for TB in the subpopulation of Latgale.